Veterinary Oncology Immunotherapies

被引：5

作者：

Bergman, Philip J. ^{[1
,2
,3
]}

机构：

[1] VCA, Clin Studies, Los Angeles, CA 90025 USA

[2] Katonah Bedford Vet Ctr, Bedford Hills, NY 10507 USA

[3] Mem Sloan Kettering Canc Ctr, New York, NY 11788 USA

来源：

VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE | 2018年 / 48卷 / 02期

关键词：

Veterinary immunotherapy; Antibody-based therapy; Cancer vaccines; ENCAPSULATED MURAMYL TRIPEPTIDE; REGULATORY T-CELLS; SURGERY ADJUVANT TREATMENTS; CYTOKINE-ENHANCED VACCINE; ORAL MALIGNANT-MELANOMA; SUICIDE GENE-THERAPY; SPONTANEOUS CANINE MELANOMA; MEDIATED IMMUNE-RESPONSES; BACILLUS-CALMETTE-GUERIN; EXON; 11; MUTATIONS;

D O I：

10.1016/j.cvsm.2017.10.004

中图分类号：

S85 [动物医学（兽医学）];

学科分类号：

0906 ;

摘要：

The ideal cancer immunotherapy agent should be able to discriminate between cancer and normal cells, be potent enough to kill small or large numbers of tumor cells, and be able to prevent recurrence of the tumor. Tumor immunology and immunotherapy are among the most exciting and rapidly expanding fields; cancer immunotherapy is now recognized as a pillar of treatment alongside traditional modalities. This article highlights approaches that seem to hold particular promise in human clinical trials and many that have been tested in veterinary medicine.

引用

页码：257 / +

页数：22

共 200 条

[1] Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy [J].

Adelfinger, Marion ;

Bessler, Simon ;

Frentzen, Alexa ;

Cecil, Alexander ;

Langbein-Laugwitz, Johanna ;

Gentschev, Ivaylo ;

Szalay, Aladar A. .

VIRUSES-BASEL, 2015, 7 (07) :4075-4092

[2] Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model [J].

Akhtar, N ;

Padilla, ML ;

Dickerson, EB ;

Steinberg, H ;

Breen, M ;

Auerbach, R ;

Helfand, SC .

NEOPLASIA, 2004, 6 (02) :106-116

[3] Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma [J].

Alexander, AN ;

Huelsmeyer, MK ;

Mitzey, A ;

Dubielzig, RR ;

Kurzman, ID ;

MacEwen, EG ;

Vail, DM .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (04) :433-442

[4] Vaccination for Invasive Canine Meningioma Induces In Situ Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity [J].

Andersen, Brian M. ;

Pluhar, G. Elizabeth ;

Seiler, Charles E. ;

Goulart, Michelle R. ;

SantaCruz, Karen S. ;

Schutten, Melissa M. ;

Meints, Joyce P. ;

O'Sullivan, M. Gerard ;

Bentley, R. Timothy ;

Packer, Rebecca A. ;

Thomovsky, Stephanie A. ;

Chen, Annie V. ;

Faissler, Dominik ;

Chen, Wei ;

Hunt, Matthew A. ;

Olin, Michael R. ;

Ohlfest, John R. .

CANCER RESEARCH, 2013, 73 (10) :2987-2997

[5]

Anderson Katie L, 2015, Vet Sci, V2, P363, DOI 10.3390/vetsci2040363

[6] A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrations [J].

Angstadt, Andrea Y. ;

Thayanithy, Venugopal ;

Subramanian, Subbaya ;

Modiano, Jaime F. ;

Breen, Matthew .

CANCER GENETICS, 2012, 205 (11) :572-587

[7]

[Anonymous], PROTEIN CELL

[8] Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks [J].

Arendt, M. ;

Nasir, L. ;

Morgan, I. M. .

VETERINARY AND COMPARATIVE ONCOLOGY, 2009, 7 (03) :153-161

[9] Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles [J].

Autio, Karoliina P. M. ;

Ruotsalainen, Janne J. ;

Anttila, Marjukka O. ;

Niittykoski, Minna ;

Waris, Matti ;

Hemminki, Akseli ;

Vaha-Koskela, Markus J. V. ;

Hinkkanen, Ari E. .

BMC VETERINARY RESEARCH, 2015, 11

[10] Cancer immunotherapy [J].

Baxevanis, Constantin N. ;

Perez, Sonia A. ;

Papamichail, Michael .

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2009, 46 (04) :167-189

← 1 2 3 4 5 6 7 8 9 10 →